GeneDx Holdings Corp.
General ticker "WGS" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $2.7B (TTM average)
GeneDx Holdings Corp. follows the US Stock Market performance with the rate: 51.8%.
Estimated limits based on current volatility of 2.4%: low 153.12$, high 159.80$
Factors to consider:
- Total employees count: 1000 as of 2024
- Current price 37.2% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [41.32$, 113.27$]
- 2025-12-31 to 2026-12-31 estimated range: [23.12$, 65.76$]
Financial Metrics affecting the WGS estimates:
- Negative: with PPE of 257.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.37 <= 0.33
- Negative: negative Net income
- Positive: 41.86 < Shareholder equity ratio, % of 58.48 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -1.45
- Positive: Interest expense per share per price, % of 0.15 <= 0.79
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term WGS quotes
Long-term WGS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $234.69MM | $202.57MM | $305.45MM |
| Operating Expenses | $902.35MM | $383.16MM | $328.66MM |
| Operating Income | $-667.65MM | $-180.60MM | $-23.21MM |
| Non-Operating Income | $69.62MM | $3.90MM | $-29.42MM |
| Interest Expense | $3.21MM | $0.00MM | $3.03MM |
| R&D Expense | $86.20MM | $58.27MM | $45.72MM |
| Income(Loss) | $-598.03MM | $-176.69MM | $-52.63MM |
| Taxes | $-49.05MM | $-0.93MM | $-0.34MM |
| Profit(Loss)* | $-548.98MM | $-175.77MM | $-52.29MM |
| Stockholders Equity | $253.71MM | $228.02MM | $245.25MM |
| Inventory | $13.66MM | $8.78MM | $10.65MM |
| Assets | $545.26MM | $418.76MM | $419.38MM |
| Operating Cash Flow | $-319.15MM | $-180.15MM | $-28.50MM |
| Capital expenditure | $14.32MM | $5.71MM | $5.49MM |
| Investing Cash Flow | $-141.33MM | $-43.73MM | $-30.13MM |
| Financing Cash Flow | $197.31MM | $186.24MM | $44.16MM |
| Earnings Per Share** | $-53.63 | $-7.23 | $-1.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.